Carret Asset Management’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$738K	Buy	559,140 +89,140	+19%	+$159K	0.07%	174
2025 Q4	$879K	Buy	470,000 +50,000	+12%	+$96.1K	0.08%	160
2025 Q3	$538K	Buy	420,000 +105,000	+33%	+$142K	0.05%	197
2025 Q2	$391K	Buy	+315,000	New	+$364K	0.04%	213
2025 Q1	–	Sell	-215,000	Closed	-$393K	–	281
2024 Q4	$393K	Buy	215,000 +52,000	+32%	+$102K	0.04%	210
2024 Q3	$277K	Buy	163,000 +85,400	+110%	+$140K	0.03%	238
2024 Q2	$106K	Buy	77,600 +45,600	+143%	+$92.1K	0.01%	269
2024 Q1	$120K	Buy	32,000 +11,000	+52%	+$64.4K	0.01%	272
2023 Q4	$206K	Buy	21,000 +4,000	+24%	+$32.7K	0.03%	262
2023 Q3	$142K	Hold	17,000	–	–	0.02%	260
2023 Q2	$226K	Hold	17,000	–	–	0.03%	242
2023 Q1	$197K	Hold	17,000	–	–	0.03%	252
2022 Q4	$139K	Hold	17,000	–	–	0.02%	267
2022 Q3	$99K	Buy	17,000 +5,000	+42%	+$28.7K	0.01%	265
2022 Q2	$53K	Buy	+12,000	New	+$72.9K	0.01%	273
2019 Q2	–	Sell	-10,000	Closed	-$72K	–	274
2019 Q1	$72K	Sell	10,000 -10,000	-50%	-$72.3K	0.01%	258
2018 Q4	$148K	Hold	20,000	–	–	0.03%	245
2018 Q3	$108K	Hold	20,000	–	–	0.02%	264
2018 Q2	$71K	Buy	20,000 +3,000	+18%	+$8.32K	0.01%	259
2018 Q1	$35K	Buy	+17,000	New	+$44.1K	0.01%	257